Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares for Tax

EVP and Chief Scientific Officer Aby J. Mathew disposed of 627 shares of BioLife Solutions common stock to satisfy tax withholding obligations.

Summary

• Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions, Inc. (BLFS), reported the disposition of 627 shares of common stock.
• The transaction occurred on June 8, 2026, at a price of $26.10 per share.
• The shares were withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following this transaction, the reporting person maintains beneficial ownership of 389,540 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the share disposition is purely administrative and related to tax compliance.

Positives

• The transaction was a routine administrative action related to tax obligations rather than a discretionary market sale.
• The reporting person retains a significant equity stake of 389,540 shares in the company.

Negatives

• The transaction represents a reduction in the direct share ownership of a key executive.

Risks

• None identified; this is a standard tax-related withholding event.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that routine tax-related share withholding is a standard practice for executives receiving equity-based compensation and does not typically signal a change in management sentiment regarding the company's future performance.

Comparison to Industry Standards

• The transaction aligns with standard corporate governance practices for equity compensation management in the biotechnology sector.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard tax-related equity adjustment.

Key Dates

Keywords

BioLife Solutions, BLFS, Insider Trading, Form 4, Executive Compensation, Tax Withholding